|
CA672478A
(en)
|
|
1963-10-15 |
Heim Roger |
Psilocybin and psilocin
|
|
LU36879A1
(https=)
|
1958-02-21 |
|
|
|
|
GB911946A
(en)
|
1958-02-21 |
1962-12-05 |
Sandoz Ltd |
Psilocybin and psilocin and processes for their preparation
|
|
US3075992A
(en)
|
1958-09-12 |
1963-01-29 |
Sandoz Ltd |
Esters of indoles
|
|
BE582353A
(https=)
|
1958-09-12 |
|
|
|
|
US3192111A
(en)
*
|
1959-02-16 |
1965-06-29 |
Sandoz Ltd |
Method of inducing therapeutic tranquilization with psilocybin and psilocin
|
|
IE24138L
(en)
|
1959-02-18 |
1959-08-21 |
Sandoz Ag |
Psilocybin and psilocin
|
|
JPS5576859A
(en)
|
1978-12-01 |
1980-06-10 |
Fujimoto Seiyaku Kk |
Novel preparation of 4-hydroxyindole
|
|
JPS5728046A
(en)
|
1980-07-28 |
1982-02-15 |
Nissan Chem Ind Ltd |
Preparation of 4-substituted indole
|
|
US4499096A
(en)
|
1983-11-18 |
1985-02-12 |
Lotsof Howard S |
Rapid method for interrupting the narcotic addiction syndrome
|
|
EP0152379A3
(de)
|
1984-02-15 |
1986-10-29 |
Ciba-Geigy Ag |
Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen
|
|
US4721612A
(en)
|
1984-04-12 |
1988-01-26 |
The Liposome Company, Inc. |
Steroidal liposomes
|
|
IL76591A0
(en)
|
1984-10-05 |
1986-02-28 |
Bioferon Biochem Substanz |
Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
|
|
US5785989A
(en)
|
1985-05-01 |
1998-07-28 |
University Utah Research Foundation |
Compositions and methods of manufacturing of oral dissolvable medicaments
|
|
US4587243A
(en)
|
1985-07-15 |
1986-05-06 |
Lotsof Howard S |
Rapid method for interrupting the cocaine and amphetamine abuse syndrome
|
|
DE3689927T3
(de)
|
1985-10-04 |
1998-10-22 |
South African Inventions |
Reagens und Verfahren.
|
|
US5725871A
(en)
|
1989-08-18 |
1998-03-10 |
Danbiosyst Uk Limited |
Drug delivery compositions comprising lysophosphoglycerolipid
|
|
WO1991003233A1
(en)
|
1989-09-05 |
1991-03-21 |
University Of Utah Research Foundation |
Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
|
|
US5629307A
(en)
|
1989-10-20 |
1997-05-13 |
Olney; John W. |
Use of ibogaine in reducing excitotoxic brain damage
|
|
US5935925A
(en)
|
1990-05-08 |
1999-08-10 |
Synaptic Pharmaceutical Corporation |
Methods of treating migraine and compounds useful for such methods
|
|
US5626863A
(en)
|
1992-02-28 |
1997-05-06 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
|
DE69133205T2
(de)
|
1990-10-19 |
2003-12-11 |
New York University, New York |
Eine methode zur transplantation von zellen in das gehirn und ihre therapeutische verwendung
|
|
US5827819A
(en)
|
1990-11-01 |
1998-10-27 |
Oregon Health Sciences University |
Covalent polar lipid conjugates with neurologically active compounds for targeting
|
|
FR2675504B1
(fr)
|
1991-04-16 |
1995-01-27 |
Delalande Sa |
Derives d'aryl-3 oxazolidinone, leur procede de preparation et leur application en therapeutique.
|
|
US5468486A
(en)
|
1992-01-21 |
1995-11-21 |
The University Of Tennessee Research Corporation |
Vaccine containing a protein alkaloid conjugate for the treatment of fescue toxicosis
|
|
EP0566135A1
(en)
|
1992-04-17 |
1993-10-20 |
Takeda Chemical Industries, Ltd. |
Transmucosal composition comprising a peptide and a cytidine derivative
|
|
US5871710A
(en)
|
1992-09-04 |
1999-02-16 |
The General Hospital Corporation |
Graft co-polymer adducts of platinum (II) compounds
|
|
US5573776A
(en)
|
1992-12-02 |
1996-11-12 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
|
EP0628042B1
(en)
|
1992-12-24 |
2001-08-16 |
PHARMACIA & UPJOHN S.p.A. |
Serotoninergic ergoline derivatives
|
|
ES2068762B1
(es)
|
1993-07-21 |
1995-12-01 |
Lipotec Sa |
Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
|
|
US5545617A
(en)
|
1993-11-12 |
1996-08-13 |
The Schepens Eye Research Institute, Inc. |
Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
|
|
US20060019963A1
(en)
|
1994-06-17 |
2006-01-26 |
Smithkline Beecham Corporation |
Compounds
|
|
ATE324897T1
(de)
|
1994-07-25 |
2006-06-15 |
Nda Int Inc |
Verwendung von noribogain derivaten zur behandlung von chemischer abhängigkeit bei säugern
|
|
US5874477A
(en)
|
1994-08-12 |
1999-02-23 |
The University Of Hawaii |
Method of treatment for malaria utilizing serotonin receptor ligands
|
|
US5696125A
(en)
|
1995-02-24 |
1997-12-09 |
Research Foundation Of The State University Of New York |
Substance abuse-induced hemorrhagic stoke in an animal model
|
|
US5643586A
(en)
|
1995-04-27 |
1997-07-01 |
Perricone; Nicholas V. |
Topical compositions and methods for treatment of skin damage and aging using catecholamines and related compounds
|
|
MX9700850A
(es)
|
1995-06-09 |
1997-09-30 |
Euro Celtique Sa |
Formulaciones y metodos para proporcionar anestesia local prolongada.
|
|
US5879690A
(en)
|
1995-09-07 |
1999-03-09 |
Perricone; Nicholas V. |
Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
|
|
DE19542281C2
(de)
|
1995-11-14 |
1997-12-04 |
Boehringer Ingelheim Kg |
Verwendung von Epinastin für die Behandlung der Migräne
|
|
FR2744361B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
FR2744364B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application d'ureidoacetamides a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
FR2744363B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application de derives de thiazolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
FR2744362B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
EP0906104A4
(en)
|
1996-03-25 |
2003-12-10 |
Lilly Co Eli |
PAIN TREATMENT PROCESS
|
|
TW448171B
(en)
|
1996-06-06 |
2001-08-01 |
Yamanouchi Pharma Co Ltd |
Imidazole-substituted quinoxalinedione derivatives
|
|
AU3290397A
(en)
|
1996-06-10 |
1998-01-07 |
Depomed, Inc. |
Gastric-retentive oral controlled drug delivery system with enhanced retention properties
|
|
US5914129A
(en)
|
1996-07-23 |
1999-06-22 |
Mauskop; Alexander |
Analgesic composition for treatment of migraine headaches
|
|
US5902815A
(en)
|
1996-09-03 |
1999-05-11 |
Washington University |
Use of 5HT-2A serotonin agonists to prevent adverse effects of NMDA receptor hypofunction
|
|
US5958919A
(en)
|
1996-09-20 |
1999-09-28 |
Washington University |
Treatment of presymptomatic alzheimer's disease to prevent neuronal degeneration
|
|
US5891885A
(en)
|
1996-10-09 |
1999-04-06 |
Algos Pharmaceutical Corporation |
Method for treating migraine
|
|
US6479074B2
(en)
|
1996-10-24 |
2002-11-12 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
|
US5804592A
(en)
|
1997-05-30 |
1998-09-08 |
Unimed Pharmaceuticals, Inc. |
Method for improving disturbed behavior and elevating mood in humans
|
|
JP2002501510A
(ja)
|
1997-05-07 |
2002-01-15 |
ユニメッド・ファーマシューティカルズ・インコーポレーテッド |
ヒトにおける攪乱行動を改善し気分を高揚させる方法
|
|
US6558956B1
(en)
|
1997-06-24 |
2003-05-06 |
The University Of Wyoming |
Method and apparatus for detection of a controlled substance
|
|
GB9715082D0
(en)
|
1997-07-17 |
1997-09-24 |
Scherer Ltd R P |
Treatment of attention deficit hyperactivity disorder and narcolepsy
|
|
US7799337B2
(en)
|
1997-07-21 |
2010-09-21 |
Levin Bruce H |
Method for directed intranasal administration of a composition
|
|
US20010004644A1
(en)
|
1997-07-21 |
2001-06-21 |
Levin Bruce H. |
Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
|
|
AU8915598A
(en)
|
1997-08-25 |
1999-03-16 |
Pentech Pharmaceuticals, Inc. |
Method for amelioration of social phobia
|
|
ATE265213T1
(de)
|
1997-09-04 |
2004-05-15 |
Novoneuron Inc |
Noribogain zur behandlung von schmerzen und drogenabhängigkeit
|
|
US7220737B1
(en)
|
1997-09-04 |
2007-05-22 |
Novoneuron, Inc |
Noribogaine in the treatment of pain and drug addiction
|
|
DE19738855C2
(de)
|
1997-09-05 |
2001-01-04 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht
|
|
US20030077227A1
(en)
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
|
US6228864B1
(en)
|
1997-10-28 |
2001-05-08 |
Vivus, Inc. |
Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
|
|
US6037346A
(en)
|
1997-10-28 |
2000-03-14 |
Vivus, Inc. |
Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
CA2306837C
(en)
|
1997-10-28 |
2007-05-08 |
Vivus, Inc. |
Treatment of female sexual dysfunction
|
|
US5922341A
(en)
|
1997-10-28 |
1999-07-13 |
Vivus, Incorporated |
Local administration of pharmacologically active agents to treat premature ejaculation
|
|
ITTO980264A1
(it)
|
1998-03-26 |
1999-09-26 |
Silvio Rossi |
Applicazione di un estratto basico non quaternario della peschiera fuchsiaefolia ad attivita' antimalarica
|
|
WO1999066909A2
(en)
|
1998-06-22 |
1999-12-29 |
Univ Kingston |
Method and compositions for the treatment or amelioration of female sexual dysfunction
|
|
AU4984899A
(en)
|
1998-07-14 |
2000-02-07 |
Adams Food Ltd. |
Nutritionally active composition for hardening fingernails
|
|
WO2000003746A2
(en)
|
1998-07-14 |
2000-01-27 |
The Brigham And Women's Hospital, Inc. |
Upregulation of type iii endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization
|
|
CA2337507A1
(en)
|
1998-07-16 |
2000-01-27 |
Massachusetts Institute Of Technology |
Composition for treatment of stress
|
|
MXPA01001180A
(es)
|
1998-07-31 |
2002-04-24 |
Vela Pharmaceuticals Inc |
Metodos y composiciones para el tratamiento y la prevencion de abuso de sustancias empleando moclobemida.
|
|
ATE310566T1
(de)
|
1998-09-18 |
2005-12-15 |
Alcon Mfg Ltd |
5ht2-agoniste zur behandlung des glaukoms
|
|
US20060025387A1
(en)
|
1998-12-23 |
2006-02-02 |
Cytoscan Sciences Llc |
Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
|
|
DE59905248D1
(de)
|
1999-01-29 |
2003-05-28 |
Disphar Int Bv |
Pharmazeutische zusammensetzungen
|
|
ATE294577T1
(de)
|
1999-02-24 |
2005-05-15 |
Univ Cincinnati |
Verwendung von sulfamat derivaten zur behandlung von impulsiven störungen
|
|
CA2368187A1
(en)
|
1999-03-19 |
2000-09-28 |
Brigham And Women's Hospital, Inc. |
Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors
|
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
WO2000059479A1
(en)
|
1999-04-06 |
2000-10-12 |
Pharmaquest Ltd. |
Pharmaceutical dosage form for pulsatile delivery of methylphenidate
|
|
ID30355A
(id)
|
1999-04-07 |
2001-11-22 |
Pfizer Prod Inc |
Penggunaan inhibitor-inhibitor cyp2d6 dalam terapi kombinasi
|
|
US6126924A
(en)
|
1999-05-27 |
2000-10-03 |
Scales-Medeiros; Virginia A. |
Light responsive self-tanning products and methods for use
|
|
US6495498B2
(en)
|
1999-05-27 |
2002-12-17 |
Johnson & Johnson Consumer Companies, Inc. |
Detergent compositions with enhanced depositing, conditioning and softness capabilities
|
|
US6489341B1
(en)
|
1999-06-02 |
2002-12-03 |
Sepracor Inc. |
Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
|
|
US20080103179A1
(en)
|
2006-10-27 |
2008-05-01 |
Tam Peter Y |
Combination Therapy
|
|
US6500459B1
(en)
|
1999-07-21 |
2002-12-31 |
Harinderpal Chhabra |
Controlled onset and sustained release dosage forms and the preparation thereof
|
|
CA2382666A1
(en)
|
1999-08-23 |
2001-03-01 |
The Administrators Of The Tulane Educational Fund |
Modulation of the blood-brain barrier transporter for leptin
|
|
US6204245B1
(en)
|
1999-09-17 |
2001-03-20 |
The Regents Of The University Of California |
Treatment of narcolepsy with immunosuppressants
|
|
AU8003800A
(en)
|
1999-10-08 |
2001-04-23 |
Joyce Corinne Bechthold |
Methods and compositions for treating neurobehavioral disorders
|
|
ES2162746B1
(es)
|
1999-10-21 |
2003-02-16 |
Lipotec Sa |
Microcapsulas para la estabilizacion de productos cosmeticos, farmaceuticos o de alimentacion.
|
|
US6693135B2
(en)
|
2000-01-10 |
2004-02-17 |
Nexmed (Holdings) Incorporated |
Prostaglandin compositions and methods of treatment for male erectile dysfunction
|
|
US20030096831A1
(en)
|
2000-01-18 |
2003-05-22 |
Stone Richard A. |
Ocular growth and nicotinic antagonists
|
|
RU2002120485A
(ru)
|
2000-01-18 |
2004-04-10 |
Волли Фордж Фармасьютикл, Инк. (Us) |
Глазной рост и никотиновые антагонисты
|
|
FR2804603B1
(fr)
|
2000-02-04 |
2004-01-23 |
Rhodia Chimie Sa |
Procede continu pour formuler sous forme de granules une ou plusieurs matieres actives pharmaceutiques
|
|
US20020015730A1
(en)
|
2000-03-09 |
2002-02-07 |
Torsten Hoffmann |
Pharmaceutical formulations and method for making
|
|
AU2001243369A1
(en)
|
2000-03-14 |
2001-09-24 |
Massachusetts Institute Of Technology |
Composition and method to treat weight gain and obesity attributable to psychotropic drugs
|
|
DE10014588A1
(de)
|
2000-03-27 |
2001-10-04 |
Basf Ag |
Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
|
|
EP1278774A2
(en)
|
2000-03-27 |
2003-01-29 |
PE Corporation (NY) |
Human g-protein coupled receptors
|
|
US6380176B2
(en)
|
2000-03-28 |
2002-04-30 |
Ajinomoto Co., Inc. |
Method for inhibiting non-intentional behavior with a running neuron inhibitory substance
|
|
DE10018834A1
(de)
|
2000-04-15 |
2001-10-25 |
Lohmann Therapie Syst Lts |
Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung
|
|
WO2001082915A2
(en)
|
2000-04-28 |
2001-11-08 |
Neal Gary W |
Trans-clitoral administration of therapy
|
|
JP4763957B2
(ja)
|
2000-05-10 |
2011-08-31 |
オバン・エナジー・リミテッド |
メディアミリング
|
|
US20020044962A1
(en)
|
2000-06-06 |
2002-04-18 |
Cherukuri S. Rao |
Encapsulation products for controlled or extended release
|
|
US20070059367A1
(en)
|
2000-06-06 |
2007-03-15 |
Cherukuri S R |
Drug Delivery System and Associated Methods
|
|
US20020019421A1
(en)
|
2000-07-05 |
2002-02-14 |
Roni Biberman |
Compositions and therapy for substance addiction
|
|
WO2002005849A2
(en)
|
2000-07-19 |
2002-01-24 |
Pitmy International N.V. |
Transportation of nucleic acid substances
|
|
EP1409530A2
(en)
|
2000-09-19 |
2004-04-21 |
Microbia, Inc. |
Modulation of secondary metabolite production by zinc binuclear cluster proteins
|
|
US9474776B2
(en)
|
2000-10-04 |
2016-10-25 |
Paul Edward Stamets |
Integrative fungal solutions for protecting bees
|
|
US9399050B2
(en)
|
2000-10-04 |
2016-07-26 |
Paul Edward Stamets |
Controlling insects and arthropods using preconidial mycelium and extracts of preconidial mycelium from entomopathogenic fungi
|
|
US20030119884A1
(en)
|
2000-11-01 |
2003-06-26 |
Epstein Mel H. |
Methods and compositions for regulating memory consolidation
|
|
US20070100000A1
(en)
|
2000-11-01 |
2007-05-03 |
Epstein Mel H |
Methods of providing neuroprotection
|
|
AR031473A1
(es)
|
2000-11-20 |
2003-09-24 |
Lundbeck & Co As H |
Intensificadores de gaba en el tratamiento de enfermedades relacionadas con una reducida actividad neuroesteroide
|
|
CA2359812C
(en)
|
2000-11-20 |
2004-02-10 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
|
|
US6495154B1
(en)
|
2000-11-21 |
2002-12-17 |
Vivus Inc. |
On demand administration of clomipramine and salts thereof to treat premature ejaculation
|
|
IL139975A0
(en)
|
2000-11-29 |
2002-02-10 |
Univ Ramot |
Anti proliferative drugs
|
|
CA2430298A1
(en)
|
2000-11-30 |
2002-06-06 |
Banavara Lakshman Mylari |
Combination of gaba agonists and sorbitol dehydrogenase inhibitors
|
|
WO2002043763A2
(en)
|
2000-11-30 |
2002-06-06 |
Pfizer Products Inc. |
Combination of gaba agonists and aldose reductase inhibitors
|
|
US20050176790A1
(en)
|
2001-02-28 |
2005-08-11 |
Johannes Bartholomaus |
Pharmaceutical salts
|
|
US20020137785A1
(en)
|
2001-03-26 |
2002-09-26 |
George Kindness |
Inflammatory mechanism modulator composition and methods with anti-asthmatic properties
|
|
US20050096396A1
(en)
|
2002-03-28 |
2005-05-05 |
Emory University |
Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
|
|
AU2002305123B2
(en)
|
2001-03-30 |
2006-10-05 |
Philadelphia Health And Education Corporation |
Immunomodulation and effect on cell processes relating to serotonin family receptors
|
|
US6632217B2
(en)
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
|
US20040132780A1
(en)
|
2001-05-04 |
2004-07-08 |
Allen Christopher P. |
Method and compositions for treating migraines
|
|
US20030051728A1
(en)
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
|
US20040023952A1
(en)
|
2001-06-20 |
2004-02-05 |
Leventhal Audie G. |
Enhanced brain function by gaba-ergic stimulation
|
|
WO2003016903A2
(de)
|
2001-08-20 |
2003-02-27 |
Walter Pils |
Vorrichtung und verfahren zum nachweis eines analyten
|
|
US6541043B2
(en)
|
2001-08-28 |
2003-04-01 |
Dexgen Pharmaceuticals, Inc. |
Method and synergistic composition for treating attention deficit/hyperactivity disorder
|
|
EP1429728A1
(en)
|
2001-08-29 |
2004-06-23 |
SRL Technologies, Inc. |
Sustained release preparations
|
|
CA2492823A1
(en)
|
2001-09-14 |
2003-03-27 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
DE60234375D1
(de)
|
2001-09-14 |
2009-12-24 |
Cytos Biotechnology Ag |
VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
|
|
KR20040039436A
(ko)
|
2001-09-27 |
2004-05-10 |
파마시아 에이비 |
약학 조성물
|
|
US7544681B2
(en)
|
2001-09-27 |
2009-06-09 |
Ramot At Tel Aviv University Ltd. |
Conjugated psychotropic drugs and uses thereof
|
|
US6592901B2
(en)
|
2001-10-15 |
2003-07-15 |
Hercules Incorporated |
Highly compressible ethylcellulose for tableting
|
|
US20060264508A1
(en)
|
2001-10-16 |
2006-11-23 |
Stone Richard A |
Modulation of ocular growth and myopia by gaba drugs
|
|
US20030082225A1
(en)
|
2001-10-19 |
2003-05-01 |
Mason Paul Arthur |
Sterile, breathable patch for treating wound pain
|
|
US7045543B2
(en)
|
2001-11-05 |
2006-05-16 |
Enzrel Inc. |
Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
|
|
EP1453468A4
(en)
|
2001-11-09 |
2005-11-23 |
Chiron Corp |
METHOD OF VACCINATION OF A HUMAN PATIENT TO PREVENT METASTATIC TUMORS
|
|
GB0127832D0
(en)
|
2001-11-20 |
2002-01-09 |
Jagotec Ag |
Method for the preparation of pharmaceutical nanosuspensions
|
|
AU2002352878B2
(en)
|
2001-11-27 |
2007-11-22 |
Merck Sharp & Dohme Corp. |
2-Aminoquinoline compounds
|
|
CA2468159A1
(en)
|
2001-11-27 |
2003-06-05 |
Merck & Co., Inc. |
4-aminoquinoline compounds
|
|
WO2003047551A1
(en)
|
2001-11-29 |
2003-06-12 |
Penwest Pharmaceutical Company |
Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
|
|
US7241797B2
(en)
|
2002-01-23 |
2007-07-10 |
University Of Cincinnati |
Method of increasing milk production
|
|
US20030171435A1
(en)
|
2002-01-23 |
2003-09-11 |
Drug Abuse Sciences, Inc. |
New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them
|
|
WO2003066029A2
(en)
|
2002-02-07 |
2003-08-14 |
Pharmacia Corporation |
Pharmaceutical dosage form for mucosal delivery
|
|
ATE346591T1
(de)
|
2002-02-07 |
2006-12-15 |
Pharmacia Corp |
Pharmazeutische tablette
|
|
US20030153552A1
(en)
|
2002-02-14 |
2003-08-14 |
Mash Deborah C. |
Method of treating chemical dependency in mammals and a composition therefor
|
|
US7700561B2
(en)
|
2002-02-22 |
2010-04-20 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
|
DE10208335A1
(de)
|
2002-02-27 |
2003-09-04 |
Roehm Gmbh |
Arzneiform und Verfahren zu ihrer Herstellung
|
|
US20030199439A1
(en)
|
2002-04-22 |
2003-10-23 |
Simon David Lew |
Compositions of alpha3beta4 receptor antagonists and opioid agonist analgesics
|
|
CN1662231A
(zh)
|
2002-04-24 |
2005-08-31 |
柏树生物科学公司 |
包括应激相关障碍在内的功能性躯体障碍的预防与治疗
|
|
AU2003228654A1
(en)
|
2002-04-29 |
2003-11-17 |
The General Hospital Corporation |
Compositions and methods for preventing abuse of orally administered medications
|
|
AUPS317102A0
(en)
|
2002-06-25 |
2002-07-18 |
Drug Delivery Solutions Pty Ltd |
Transdermal aerosol compositions
|
|
JP2005537244A
(ja)
|
2002-06-28 |
2005-12-08 |
ナステック・ファーマシューティカル・カンパニー・インコーポレーテッド |
療法化合物の粘膜搬送を増進させるための、上皮接合部接着分子の生理機能を調節する組成物および方法
|
|
US20040006043A1
(en)
|
2002-07-02 |
2004-01-08 |
Ramot University Authority For Applied Research & Industrial Development Ltd. |
Methods, pharmaceutical compositions and pharmaceutical kits for enhancing the therapeutic efficiency of cancer chemotherapeutic agents
|
|
US10738268B2
(en)
|
2016-08-21 |
2020-08-11 |
Insectergy, Llc |
Cannabis nanoemulsion methods
|
|
US20050148673A1
(en)
|
2002-07-11 |
2005-07-07 |
Harbut Ronald E. |
Prolonged administration of NMDA antagonist and safener drug to alter neuropathic pain condition
|
|
US7138252B2
(en)
|
2002-07-17 |
2006-11-21 |
Cytos Biotechnology Ag |
Molecular antigen arrays
|
|
CA2487849A1
(en)
|
2002-07-18 |
2004-01-29 |
Cytos Biotechnology Ag |
Hapten-carrier conjugates comprising virus like particles and uses thereof
|
|
US7838034B2
(en)
|
2002-07-30 |
2010-11-23 |
Grunenthal Gmbh |
Intravenous pharmaceutical form of administration
|
|
JPWO2004014429A1
(ja)
|
2002-08-09 |
2005-12-02 |
三菱ウェルファーマ株式会社 |
精神疾患発症脆弱性制御剤
|
|
US20030114512A1
(en)
|
2002-09-09 |
2003-06-19 |
Collier Robert J |
Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma
|
|
AU2003278832A1
(en)
|
2002-09-13 |
2004-04-30 |
Carnegie Mellon University |
Optical biosensors and methods of use thereof
|
|
WO2004026290A1
(en)
|
2002-09-19 |
2004-04-01 |
Merck & Co., Inc. |
Method for treating depression and/or anxiety
|
|
US6913768B2
(en)
|
2002-09-24 |
2005-07-05 |
Shire Laboratories, Inc. |
Sustained release delivery of amphetamine salts
|
|
DE10244504A1
(de)
|
2002-09-25 |
2004-04-08 |
Capsulution Nanoscience Ag |
Schnellfreisetzende Darreichungsform mit schwerlöslichem Wirkstoff
|
|
CN1703199B
(zh)
|
2002-10-11 |
2010-04-28 |
伊迪亚股份公司 |
具有增强的可变形性、包含至少三种两亲性物质的聚集物,其用于改善通过半透屏障的转运以及非侵入性药物在体内、具体是通过皮肤的应用
|
|
WO2004111185A2
(en)
|
2002-10-30 |
2004-12-23 |
The Regents Of The University Of California |
Direct micro-patterning of lipid bilayers using uv light and selected uses thereof
|
|
DE10250944B9
(de)
|
2002-10-31 |
2004-09-16 |
Cell Center Cologne Gmbh |
Verwendung eines Stifts zur Applikation von Pflege- oder Wirkstoffen in die Nase
|
|
US7670627B2
(en)
|
2002-12-09 |
2010-03-02 |
Salvona Ip Llc |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
|
|
AU2003292936A1
(en)
|
2002-12-24 |
2004-07-22 |
Neurochem (International) Limited |
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
|
PT1587789E
(pt)
|
2003-01-16 |
2008-12-16 |
Acadia Pharm Inc |
Agonistas inversos selectivos para receptores 2a/2c da serotonina como agentes terapêuticos para doenças neurodegenerativas
|
|
JP2006515628A
(ja)
|
2003-01-23 |
2006-06-01 |
アカディア ファーマシューティカルズ，インコーポレーテッド |
ヒト神経精神疾患を処置するためのｎ−デスメチルクロザピンの使用
|
|
US20040186155A1
(en)
|
2003-01-30 |
2004-09-23 |
Dayno Jeffrey Marc |
Combination therapy for the treatment or prevention of migraine
|
|
WO2004071431A2
(en)
|
2003-02-05 |
2004-08-26 |
Myriad Genetics, Inc. |
Method and composition for treating neurodegenerative disorders
|
|
US20040214215A1
(en)
|
2003-03-07 |
2004-10-28 |
Yu Ruey J. |
Bioavailability and improved delivery of alkaline pharmaceutical drugs
|
|
DK1610796T3
(da)
|
2003-03-17 |
2014-07-21 |
Neurohealing Pharmaceuticals Inc |
Højpotent dopaminerg behandling af neurologisk svækkelse, som er forbundet med hjerneskade
|
|
AU2004224761A1
(en)
|
2003-03-26 |
2004-10-07 |
Cytos Biotechnology Ag |
HIV-peptide-carrier-conjugates
|
|
US8906413B2
(en)
|
2003-05-12 |
2014-12-09 |
Supernus Pharmaceuticals, Inc. |
Drug formulations having reduced abuse potential
|
|
SI1644019T2
(en)
|
2003-05-29 |
2018-04-30 |
Shire Llc |
Abuse resistant amphetamine compounds
|
|
EP1635815A4
(en)
|
2003-06-03 |
2009-03-25 |
Beth Israel Hospital |
METHOD AND COMPOUNDS FOR TREATING TISSUE TESTS
|
|
US20070065463A1
(en)
|
2003-06-20 |
2007-03-22 |
Ronald Aung-Din |
Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
|
|
JP4174016B2
(ja)
|
2003-07-11 |
2008-10-29 |
株式会社ビーエル |
競合法によるサイロシン類のイムノクロマトグラフィー検出法及びテストキット
|
|
WO2005007628A1
(en)
|
2003-07-11 |
2005-01-27 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
|
DE10334188B4
(de)
|
2003-07-26 |
2007-07-05 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung von Depressionen
|
|
DE10338174A1
(de)
|
2003-08-20 |
2005-03-24 |
Lts Lohmann Therapie-Systeme Ag |
Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
|
|
US20050203011A1
(en)
|
2003-09-19 |
2005-09-15 |
The Regents Of The University Of California |
Mitigating symptoms and behaviors of substance abuse by modulating GDNF or BDNF pathway activity
|
|
US20050070501A1
(en)
|
2003-09-29 |
2005-03-31 |
New York Blood Center, Inc. |
Water dispersible film
|
|
JP4641942B2
(ja)
|
2003-10-03 |
2011-03-02 |
フェーイレン・ナムローゼ・フェンノートシャップ |
ヒトおよび動物におけるｉｇｆ−１血清レベルの低下と関連した種々の疾患状態の治療用の治療用組成物の製造のための血清中ｉｇｆ−１レベルを増加できる化合物の使用
|
|
WO2005037199A2
(en)
|
2003-10-10 |
2005-04-28 |
Bristol-Myers Squibb Company |
Pyrazole derivatives as cannabinoid receptor modulators
|
|
US20070053954A1
(en)
|
2003-10-24 |
2007-03-08 |
Rowe Stephen C |
Macromer-melt formulations
|
|
CA2585024A1
(en)
|
2003-10-24 |
2005-05-06 |
Azopax Therapeutics Llc |
Macromer-melt formulations
|
|
JP2005132747A
(ja)
|
2003-10-29 |
2005-05-26 |
Ajinomoto Co Inc |
老齢伴侶動物の老化行動改善剤
|
|
EP1701725B1
(en)
|
2003-12-16 |
2013-07-31 |
Relevare Aust. Pty Ltd |
Compositions comprising flupirtine and an opioid for use in the treatment of neuropathic pain
|
|
US20050260258A1
(en)
|
2003-12-18 |
2005-11-24 |
The Texas A&M University System |
Use of vitelline protein B as a microencapsulating additive
|
|
US20050215521A1
(en)
|
2003-12-22 |
2005-09-29 |
Karim Lalji |
Modafinil combination therapy for improving sleep quality
|
|
WO2005063296A2
(en)
|
2003-12-23 |
2005-07-14 |
Pfizer Products Inc. |
Therapeutic combination for cognition enhancement and psychotic disorders
|
|
GB0400802D0
(en)
|
2004-01-14 |
2004-02-18 |
Daniolabs Ltd |
Compounds for the treatment of disease
|
|
EP1715843A1
(en)
|
2004-01-29 |
2006-11-02 |
Neuromolecular Inc. |
Combination of a nmda receptor antagonist and a mao-inhibitor or a gadph-inhibitor for the treatment of central nervous system-related conditions
|
|
WO2005079756A2
(en)
|
2004-02-13 |
2005-09-01 |
Neuromolecular, Inc. |
Combination of a nmda receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
|
|
WO2005079773A2
(en)
|
2004-02-13 |
2005-09-01 |
Neuromolecular, Inc. |
Combination of an nmda receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other cns disorders
|
|
US7981441B2
(en)
|
2004-02-18 |
2011-07-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Drug delivery systems using mesoporous oxide films
|
|
US20050222270A1
(en)
|
2004-02-26 |
2005-10-06 |
Olney John W |
Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasis
|
|
FR2867075B1
(fr)
|
2004-03-03 |
2006-07-14 |
Ethypharm Sa |
Procede de preparation de microspheres biodegradables calibrees
|
|
AU2005222640A1
(en)
|
2004-03-12 |
2005-09-29 |
The Mclean Hospital Corporation |
Salvinorin derivatives and uses thereof
|
|
US20060270592A1
(en)
|
2004-03-19 |
2006-11-30 |
Ophthalmic Research Associates, Inc. |
Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
|
|
EP1737473A4
(en)
|
2004-04-19 |
2009-08-26 |
Noven Therapeutics Llc |
COMBINATIONS OF LITHIUM AND USES THEREOF
|
|
WO2005102390A2
(en)
|
2004-04-22 |
2005-11-03 |
Pfizer Japan, Inc. |
Combinations comprising alpha-2-delta ligands and nmda receptor antagonists
|
|
RU2253461C1
(ru)
|
2004-04-30 |
2005-06-10 |
Общество с ограниченной ответственностью "Паркинфарм" |
Фармацевтическая комбинация, оказывающая влияние на функционирование цнс, способ коррекции состояний, связанных с нарушениями функционирования цнс; фармацевтический набор; средство, способствующее проникновению через гематоэнцефалический барьер лекарственных субстанций и метаболитов; фармацевтическое средство для эндоназального применения
|
|
US20050255091A1
(en)
|
2004-05-14 |
2005-11-17 |
Loomis Gary L |
Hydrogels for biomedical applications
|
|
US20050261278A1
(en)
|
2004-05-21 |
2005-11-24 |
Weiner David M |
Selective serotonin receptor inverse agonists as therapeutics for disease
|
|
US20050265955A1
(en)
|
2004-05-28 |
2005-12-01 |
Mallinckrodt Inc. |
Sustained release preparations
|
|
NL1026634C2
(nl)
|
2004-07-12 |
2006-01-16 |
Willem Jacob Van Der Burg |
Psychofarmaceutisch preparaat en werkzame stof daarin.
|
|
US7799802B2
(en)
|
2004-08-03 |
2010-09-21 |
Institstute of Oriental Medical Science Inc. |
Method and health food for preventing and/or alleviating psychiatric disorder, and/or for effectuating sedation
|
|
US20060030625A1
(en)
|
2004-08-06 |
2006-02-09 |
Cheryle Ram Hart |
Dietary neurotransmitter precursors for balanced synthesis of neurotransmitters
|
|
US20060045865A1
(en)
|
2004-08-27 |
2006-03-02 |
Spherics, Inc. |
Controlled regional oral delivery
|
|
EP2347765B1
(en)
|
2004-09-24 |
2014-01-22 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating complications of pregnancy
|
|
US7655691B2
(en)
|
2004-09-27 |
2010-02-02 |
Sard Howard P |
Indole compounds useful as serotonin selective agents
|
|
US20060240043A1
(en)
|
2004-10-08 |
2006-10-26 |
Meyerson Laurence R |
Methods and compositions for treating migraine pain
|
|
AU2005306579B2
(en)
|
2004-11-22 |
2012-01-19 |
Immuron Limited |
Bioactive compositions
|
|
FR2878161B1
(fr)
|
2004-11-23 |
2008-10-31 |
Flamel Technologies Sa |
Forme medicamenteuse orale, solide et concue pour eviter le mesusage
|
|
US20060110327A1
(en)
|
2004-11-24 |
2006-05-25 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
FR2878158B1
(fr)
|
2004-11-24 |
2009-01-16 |
Flamel Technologies Sa |
Forme pharmaceutique orale, microparticulaire solide concue pour eviter le mesusage
|
|
US7294649B2
(en)
|
2004-12-17 |
2007-11-13 |
Roche Diagnostics Operatins, Inc. |
Methamphetamine derivatives and conjugates for immunoassay
|
|
CN101132777A
(zh)
|
2004-12-20 |
2008-02-27 |
科利吉姆制药公司 |
用于睡眠障碍的药物组合物
|
|
US20060192098A1
(en)
|
2005-01-10 |
2006-08-31 |
Smiths Detection Inc. |
Sampling swab
|
|
DE102005004343A1
(de)
|
2005-01-25 |
2006-08-10 |
Eberhard-Karls-Universität Tübingen Universitätsklinikum |
Behandlung von Phantomphänomenen
|
|
FR2881652B1
(fr)
|
2005-02-08 |
2007-05-25 |
Flamel Technologies Sa |
Forme pharmaceutique orale microparticulaire anti-mesuage
|
|
US8318210B2
(en)
|
2005-02-28 |
2012-11-27 |
Neos Therapeutics, Lp |
Compositions and methods of making sustained release liquid formulations
|
|
ES2573539T3
(es)
|
2005-03-21 |
2016-06-08 |
Teva Czech Industries S.R.O. |
Inhibidor de la cristalización y su uso en cápsulas de gelatina
|
|
ES2391030T3
(es)
|
2005-03-23 |
2012-11-20 |
Bpsi Holdings, Llc. |
Composiciones de almidón aglomerado
|
|
EP1863454A2
(en)
|
2005-03-28 |
2007-12-12 |
Orexo AB |
New pharmaceutical compositions useful in the treatment of migraine
|
|
US20060229293A1
(en)
|
2005-04-06 |
2006-10-12 |
Addiction Research Institute, Inc. |
Compositions for the treatment of hepatitis C and methods for using compositions for the treatment of hepatitis C
|
|
BRPI0612440A2
(pt)
|
2005-04-08 |
2010-11-23 |
New River Pharmaceuticals Inc |
composição farmacêutica e uso de um profármaco de anfetamina
|
|
JP2008536866A
(ja)
|
2005-04-15 |
2008-09-11 |
ボード、オブ、トラスティーズ、オブ、ミシガン、ステイト、ユニバーシティ |
アミン作動性医薬組成物および方法
|
|
WO2007004067A2
(en)
|
2005-04-15 |
2007-01-11 |
Interface Biologics Inc. |
Methods and compositions for the delivery of biologically active agents
|
|
CA2605580A1
(en)
|
2005-04-22 |
2006-11-02 |
Wyeth |
Benzodioxane and benzodioxolane derivatives and uses thereof
|
|
EP1877382B1
(en)
|
2005-05-06 |
2012-11-28 |
Smiths Detection Inc. |
Method of using isobutyramide as an ionization reagent in IMS-spectrometry
|
|
US8859585B2
(en)
|
2005-05-25 |
2014-10-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Scopolamine for the treatment of depression and anxiety
|
|
GB0511060D0
(en)
|
2005-05-31 |
2005-07-06 |
Novartis Ag |
Organic compounds
|
|
CA2610838A1
(en)
|
2005-06-07 |
2006-12-14 |
Ramot At Tel Aviv University Ltd. |
Novel salts of conjugated psychotropic drugs and processes of preparing same
|
|
CA2612309C
(en)
|
2005-06-16 |
2014-12-16 |
Mohammed Saeed |
Composition and method for inhibiting, preventing, or ameliorating complications associated with ingestion of a medicinal, chemical, or biological substance or agent
|
|
US7645802B2
(en)
|
2005-06-27 |
2010-01-12 |
Biovail Laboratories International Srl. |
Bupropion hydrobromide and therapeutic applications
|
|
US9198862B2
(en)
|
2005-07-22 |
2015-12-01 |
Rubicon Research Private Limited |
Dispersible tablet composition
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
US20070092586A1
(en)
|
2005-10-26 |
2007-04-26 |
Alamo Pharmaceuticals |
Compositions and methods for the administration psychotropic drugs which modulate body weight
|
|
DE102005055866A1
(de)
|
2005-11-23 |
2007-05-24 |
Hte Ag The High Throughput Experimentation Company |
Verfahren zur Herstellung von Aryl-Aryl gekoppelter Verbindungen
|
|
KR20080089653A
(ko)
|
2006-01-21 |
2008-10-07 |
애보트 게엠베하 운트 콤파니 카게 |
남용 약물의 전달을 위한 투여형 및 방법
|
|
CN101336116B
(zh)
|
2006-02-02 |
2013-01-02 |
医学技术设备公司 |
一种包含溶胶-凝胶组合物的生物活性物质输送系统
|
|
US20070203216A1
(en)
|
2006-02-14 |
2007-08-30 |
Bjarke Ebert |
Method of treating inflammatory diseases
|
|
US20070190130A1
(en)
|
2006-02-16 |
2007-08-16 |
Mark William A |
Protein hydrolysate excipients
|
|
US20080075789A1
(en)
|
2006-02-28 |
2008-03-27 |
The Regents Of The University Of California |
Genes differentially expressed in bipolar disorder and/or schizophrenia
|
|
CA2644311C
(en)
|
2006-03-01 |
2012-07-10 |
Tristrata, Inc. |
Composition and method for topical treatment of tar-responsive dermatological disorders
|
|
FR2898271B1
(fr)
|
2006-03-09 |
2009-01-16 |
Pierre Fabre Medicament Sa |
Nouvelle utilisation d'agents antihistaminiques pour le traitement preventif ou procede de syndromes inflammatoires, en particulier ceux declenches par les toga virus.
|
|
AU2007229866A1
(en)
|
2006-03-22 |
2007-10-04 |
Mount Sinai School Of Medicine |
Intranasal administration of ketamine to treat depression
|
|
WO2006079999A2
(en)
|
2006-04-09 |
2006-08-03 |
Barth Frederik H |
Induction of a novel state of mind with a 5-ht2a agonist and a nmda antagonist
|
|
JP2009533519A
(ja)
|
2006-04-14 |
2009-09-17 |
インターフェース バイオロジクス，インコーポレーテッド |
グラフトポリマーおよびその使用
|
|
GB0608647D0
(en)
|
2006-05-02 |
2006-06-14 |
Haritou Susan J A |
Methods of diagnosis and treatment
|
|
ES2529455T3
(es)
|
2006-05-12 |
2015-02-20 |
Shire Llc |
Sistema de administración de fármacos por dosis controladas
|
|
US8846100B2
(en)
|
2006-05-12 |
2014-09-30 |
Shire Llc |
Controlled dose drug delivery system
|
|
WO2008003028A2
(en)
|
2006-06-28 |
2008-01-03 |
Chelsea Therapeutics, Inc. |
Pharmaceutical compositions comprising droxidopa
|
|
WO2008053362A2
(en)
|
2006-06-30 |
2008-05-08 |
Interface Biologics, Inc. |
Bioresponsive polymers
|
|
WO2008010223A2
(en)
|
2006-07-17 |
2008-01-24 |
Ramot At Tel Aviv University Ltd. |
Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use in treating pain and other cns disorders
|
|
US20090312306A1
(en)
|
2006-07-20 |
2009-12-17 |
Guangri Sun |
Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands
|
|
US20080026189A1
(en)
|
2006-07-27 |
2008-01-31 |
Chun-Wei Lin |
Thin key structure for generating dazzling light
|
|
BRPI0715633A2
(pt)
|
2006-08-23 |
2013-07-02 |
Univ Montana |
mÉtodo de reduÇço de dano em cÉlula neuronal
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
WO2008026046A1
(en)
|
2006-08-30 |
2008-03-06 |
Pfizer Products Inc. |
Morpholine d3 dopamine antagonists
|
|
EP2081429A4
(en)
|
2006-08-31 |
2010-01-06 |
Biogen Idec Inc |
PROCESS FOR PERIPHERAL ADMINISTRATION OF NOGO RECEPTOR POLYPEPTIDES
|
|
AU2007299920A1
(en)
|
2006-09-19 |
2008-03-27 |
Braincells, Inc. |
PPAR Mediated Modulation of Neurogenesis
|
|
US20080066739A1
(en)
|
2006-09-20 |
2008-03-20 |
Lemahieu Edward |
Methods and systems of delivering medication via inhalation
|
|
EP2083825A4
(en)
|
2006-09-26 |
2009-11-04 |
Addiction Res Inst Inc |
HEPATITIS C TREATMENT COMPOSITIONS AND METHODS OF USING HEPATITIS C TREATMENT COMPOSITIONS
|
|
WO2008038291A1
(en)
|
2006-09-27 |
2008-04-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Combination of liposomal anti-cancer drugs and lysosome/endosome ph increasing agents for therapy
|
|
WO2008051599A2
(en)
|
2006-10-27 |
2008-05-02 |
Medivation Neurology, Inc. |
Combination therapies for treating alzheimer's disease using i. a. dimebon and dolepezil
|
|
MX2009004552A
(es)
|
2006-10-27 |
2009-11-10 |
Janssen Pharmaceutica Nv |
Metodos de tratamiento de trastornos de comportamiento perturbador.
|
|
MX2009004798A
(es)
|
2006-10-31 |
2009-08-12 |
Janssen Pharmaceutica Nv |
Tratamiento de los trastornos generalizados del desarrollo.
|
|
US8653106B2
(en)
|
2010-07-30 |
2014-02-18 |
Pisgah Laboratories, Inc. |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
|
|
US7718649B1
(en)
|
2006-11-10 |
2010-05-18 |
Pisgah Labs, Inc. |
Physical states of a pharmaceutical drug substance
|
|
US20080293695A1
(en)
|
2007-05-22 |
2008-11-27 |
David William Bristol |
Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
|
|
US9823737B2
(en)
*
|
2008-04-07 |
2017-11-21 |
Mohammad A Mazed |
Augmented reality personal assistant apparatus
|
|
US10529003B2
(en)
*
|
2008-04-07 |
2020-01-07 |
Mohammad A. Mazed |
Optical biomodule for detection of diseases at an early onset
|
|
WO2008073918A1
(en)
|
2006-12-11 |
2008-06-19 |
Kempharm, Inc. |
Non-standard amino acid conjugates of amphetamine and processes for making and using the same
|
|
ES2302650B1
(es)
|
2007-01-11 |
2009-02-16 |
Tedec-Meiji Farma, S.A. |
Composicion de rapida desintegracion en la cavidad bucal.
|
|
US20100076006A1
(en)
|
2007-01-31 |
2010-03-25 |
University Of Virginia Patent Foundation |
Topiramate Plus Naltrexone for the Treatment of Addictive Disorders
|
|
AU2008213643A1
(en)
|
2007-02-08 |
2008-08-14 |
Kempharm, Inc. |
Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same
|
|
ES2500053T3
(es)
|
2007-03-09 |
2014-09-29 |
Chelsea Therapeutics, Inc. |
Composición farmacéutica que comprende droxidopa para el tratamiento de la fibromialgia
|
|
WO2008112773A2
(en)
|
2007-03-12 |
2008-09-18 |
Chelsea Therapeutics, Inc. |
Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension
|
|
US20080226715A1
(en)
|
2007-03-16 |
2008-09-18 |
Albert Cha |
Therapeutic compositions and methods
|
|
DE102007014286A1
(de)
|
2007-03-19 |
2008-09-25 |
Universität Tübingen |
Fluorsubstituierte Amphetamine und Amphetaminderivate und deren Verwendung
|
|
CN102014995B
(zh)
|
2007-03-30 |
2015-05-13 |
菲利普莫里斯生产公司 |
用于输送药剂的装置和方法
|
|
AT505086B1
(de)
|
2007-04-02 |
2009-06-15 |
Planta Naturstoffe Vertriebsge |
Pharmazeutisches mittel gegen juckreiz und juckreizbedingten schmerz
|
|
WO2008122990A1
(en)
|
2007-04-04 |
2008-10-16 |
Almet Corporation Limited |
Compacting upflow extractor and method of using it
|
|
WO2008128193A1
(en)
|
2007-04-12 |
2008-10-23 |
Rutgers, The State University Of New Jersey |
Biodegradable polyanhydrides with natural bioactive molecules
|
|
EP2062903A1
(en)
|
2007-04-18 |
2009-05-27 |
Teva Pharmaceutical Industries Ltd. |
Statin intermediates and process for the preparation of statins
|
|
BRPI0809843A2
(pt)
|
2007-04-26 |
2014-09-23 |
Auspex Pharmaceuticals Inc |
"composto, composição farmacêutica e uso de um composto"
|
|
US9421266B2
(en)
|
2007-05-22 |
2016-08-23 |
Pisgah Laboratories, Inc. |
Safety of pseudoephedrine drug products
|
|
US10183001B1
(en)
|
2007-05-22 |
2019-01-22 |
Pisgah Laboratories, Inc. |
Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
|
|
JP2011500512A
(ja)
|
2007-07-31 |
2011-01-06 |
リメリック バイオファーマ，インコーポレイティド |
リン酸化ピロン類似体および方法
|
|
US20090036468A1
(en)
|
2007-08-03 |
2009-02-05 |
Forest Laboratories Holdings Limited |
Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine receptor ligands
|
|
FR2919861A1
(fr)
|
2007-08-06 |
2009-02-13 |
Sanofi Aventis Sa |
Le solvate d'isopranol de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
|
|
AU2016208412A1
(en)
|
2007-08-06 |
2016-08-18 |
Biotie Therapies, Inc. |
Methods for treating dependence
|
|
EP3251670A1
(en)
|
2007-08-06 |
2017-12-06 |
Biotie Therapies, Inc. |
Methods for treating dependence
|
|
JP5358571B2
(ja)
|
2007-08-07 |
2013-12-04 |
プロサリク リミテッド |
セロトニン作動性調節因子としての１，２，４−トリアゾール誘導体
|
|
US8067028B2
(en)
|
2007-08-13 |
2011-11-29 |
Confluent Surgical Inc. |
Drug delivery device
|
|
US8318813B2
(en)
|
2007-09-13 |
2012-11-27 |
Lcs Group, Llc |
Method of treating binge eating disorder
|
|
JP5599712B2
(ja)
|
2007-10-05 |
2014-10-01 |
インターフェース バイオロジクス，インコーポレーテッド |
オリゴフッ素化架橋ポリマーおよびそれの使用
|
|
WO2009049215A1
(en)
|
2007-10-10 |
2009-04-16 |
Wake Forest University Health Sciences |
Methods to reduce the effects of sleep deprivation
|
|
WO2009055001A2
(en)
|
2007-10-23 |
2009-04-30 |
Fred Hutchinson Cancer Research Center |
Methods of treating aging and methods of screening candidate agents therefor
|
|
WO2009061436A1
(en)
|
2007-11-06 |
2009-05-14 |
University Of Florida Research Foundation |
Compound for activating 5-ht2c receptors in combination with an amphetamine compound
|
|
DE102007063210A1
(de)
|
2007-12-20 |
2009-06-25 |
Eberhard-Karls-Universität Tübingen Universitätsklinikum |
Arzneimittel zur Behandlung von Phantomphänomenen
|
|
WO2009079765A1
(en)
|
2007-12-21 |
2009-07-02 |
Cascade Therapeutics Inc. |
Compounds with activity at the 5-ht2c receptor
|
|
US20090176792A1
(en)
|
2008-01-07 |
2009-07-09 |
Auspex Pharmaceuticals, Inc. |
Substituted dibenzhydrylpiperazines
|
|
EP3090743A1
(en)
|
2008-01-09 |
2016-11-09 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions for treating headache and eliminating nausea
|
|
WO2009091605A2
(en)
|
2008-01-17 |
2009-07-23 |
Health Innovations, Llc |
Taste titration therapies
|
|
AU2016203452B2
(en)
*
|
2008-01-22 |
2018-02-22 |
Araim Pharmaceuticals, Inc. |
Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
|
|
KR20200075044A
(ko)
*
|
2008-01-22 |
2020-06-25 |
아라임 파마슈티칼즈, 인크. |
조직 손상 관련 질환 및 장애를 예방 및 치료하기 위한 조직 보호 펩티드 및 펩티드 유사체
|
|
AU2014203195B2
(en)
*
|
2008-01-22 |
2016-03-31 |
Araim Pharmaceuticals, Inc. |
Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
|
|
US8329663B2
(en)
|
2008-01-31 |
2012-12-11 |
Paul Griffin |
Compositions and methods for the treatment of chronic infections
|
|
WO2009097596A1
(en)
|
2008-01-31 |
2009-08-06 |
Paul Griffin |
Compositions and methods for the treatment of chronic infections
|
|
AU2009209565B2
(en)
|
2008-02-01 |
2013-09-19 |
Ascendis Pharma As |
Prodrug comprising a self-cleavable linker
|
|
CA2713879C
(en)
|
2008-02-01 |
2020-01-07 |
Alpha-O Peptides Ag |
Self-assembling peptide nanoparticles useful as vaccines
|
|
US20090198145A1
(en)
|
2008-02-06 |
2009-08-06 |
Chow Harrison |
Compositions, methods, and systems for rapid induction and maintenance of continuous rem sleep
|
|
AU2009214724A1
(en)
|
2008-02-11 |
2009-08-20 |
Organix Inc. |
Indole compounds and methods of use thereof
|
|
US8859579B2
(en)
|
2008-03-21 |
2014-10-14 |
Richard Andrew Sewell |
Compostions and methods for preventing and/or treating disorders associated with cephalic pain
|
|
JP2011515433A
(ja)
|
2008-03-26 |
2011-05-19 |
ロンザ リミテッド |
エチニルシクロプロパンの合成方法
|
|
US20170276676A1
(en)
|
2008-03-27 |
2017-09-28 |
Gus J. Slotman |
System for assessing drug efficacy and response of a patient to therapy
|
|
WO2009118763A1
(en)
|
2008-03-28 |
2009-10-01 |
Panacea Biotec Limited |
Multilayered pharmaceutical compositions and processes thereof
|
|
US20090252786A1
(en)
|
2008-03-31 |
2009-10-08 |
Christoph Hanz |
Use of a Biologically Active Blood Serum for the Treatment of a Disorder Characterized in a Reduced Function of a GABA Receptor
|
|
EP2106799A1
(en)
|
2008-03-31 |
2009-10-07 |
OWEN Holding LTD |
Use of a biologically active blood serum for the treatment of a disorder characterized in a reduced function of a GABA receptor
|
|
FR2930147B1
(fr)
|
2008-04-18 |
2013-02-08 |
Flamel Tech Sa |
Forme orale solide dotee d'un double profil de liberation
|
|
ES2563061T3
(es)
|
2008-04-28 |
2016-03-10 |
Zogenix, Inc. |
Nuevas formulaciones para el tratamiento de la migraña
|
|
US20110086063A1
(en)
|
2008-06-04 |
2011-04-14 |
Cornell University |
Vaccines for prevention and treatment of addiction
|
|
US10388179B2
(en)
|
2008-06-18 |
2019-08-20 |
Accenture Global Solutions Limited |
Analytics platform
|
|
EP2285362B1
(en)
|
2008-06-19 |
2017-08-09 |
LTS LOHMANN Therapie-Systeme AG |
Composition for transdermal delivery of cationic active agents
|
|
EP2313037A1
(en)
|
2008-06-30 |
2011-04-27 |
Oron Zachar |
Dermal application of vasoconstrictors
|
|
US9642819B2
(en)
|
2008-07-10 |
2017-05-09 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical |
Low dosage serotonin 5-HT2A receptor agonist to suppress inflammation
|
|
WO2010006249A1
(en)
|
2008-07-10 |
2010-01-14 |
Tyrx Pharma, Inc. |
Sustained release formulations of psychoactive drugs
|
|
MX2011001384A
(es)
|
2008-08-06 |
2011-09-27 |
Gosforth Ct Holdings Pty Ltd |
Composiciones y metodos para tratar trastornos psiquiatricos.
|
|
FR2935611B1
(fr)
|
2008-09-10 |
2010-10-15 |
Commissariat Energie Atomique |
Utilisation d'agents anti-connexines pour moduler l'effet therapeutique de molecules psychotropes
|
|
FR2936710B1
(fr)
|
2008-10-07 |
2011-01-07 |
Ceva Sante Animale |
Composition veterinaire antiprolactinique destinee aux ruminants
|
|
EP2389187B1
(en)
|
2009-01-20 |
2016-11-16 |
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center |
Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical
|
|
UA105657C2
(uk)
|
2009-02-27 |
2014-06-10 |
Хелсінн Терапьютікс (Ю.Ес.), Інк. |
Поліпшені способи лікування мігрені на основі анамореліну
|
|
WO2010124089A2
(en)
|
2009-04-22 |
2010-10-28 |
Synosia Therapeutics, Inc. |
Methods for treating dependence
|
|
WO2010123577A2
(en)
|
2009-04-24 |
2010-10-28 |
Galenea Corp. |
Compositions and methods for evaluating cognitive deficits
|
|
CA2763172A1
(en)
|
2009-05-26 |
2010-12-02 |
David Hackett |
Methods of enhancing selective serotonin reuptake inhibitor effects in mammals
|
|
GB201111485D0
(en)
|
2011-07-05 |
2011-08-17 |
Biocopea Ltd |
Drug composition and its use in therapy
|
|
US20110306596A1
(en)
|
2009-07-27 |
2011-12-15 |
Auspex Pharmaceuticals, Inc. |
Benzazepine inhibitors of gamma-secretase
|
|
US20120302590A1
(en)
|
2009-08-13 |
2012-11-29 |
The General Hospital Corporation |
Methods and compositions to prevent addiction
|
|
US20110038915A1
(en)
|
2009-08-14 |
2011-02-17 |
Eduardo Jose Gonzalez |
Chewing Gum Formula for Enhancing Psycho-Spirituality
|
|
WO2011028875A1
(en)
|
2009-09-03 |
2011-03-10 |
Wake Forest University Health Sciences |
Immunogenic conjugates for producing immune responses to drugs of abuse and methods of use
|
|
WO2011027060A2
(fr)
|
2009-09-04 |
2011-03-10 |
Centre National De La Recherche Scientifique - Crns - |
Traitement par l'ocytocine de caracteristiques comportementales associees a l'autisme et a la timidite pathologique
|
|
US20120282299A1
(en)
|
2009-10-16 |
2012-11-08 |
Soazig Claude Marie Delamarre |
Coatings comprising bis-(alpha-amino-diol-diester) containing polyesteramide
|
|
FR2951378B1
(fr)
|
2009-10-16 |
2012-06-01 |
Flamel Tech Sa |
Forme pharmaceutique orale solide anti-mesusage et dotee d'un profil specifique de liberation modifiee
|
|
EP2490677A2
(en)
|
2009-10-19 |
2012-08-29 |
Intec Pharma Ltd. |
Novel gastroretentive dosage forms of poorly soluble drugs
|
|
CN102933658A
(zh)
|
2009-12-18 |
2013-02-13 |
界面生物公司 |
从自组装涂层局部递送药物
|
|
JP5792748B2
(ja)
|
2010-02-06 |
2015-10-14 |
タール ファーマシューティカルズ，インコーポレイテッド |
結晶化法及びバイオアベイラビリティ
|
|
US20110217289A1
(en)
|
2010-03-05 |
2011-09-08 |
Basf Se |
Melt-Coated Dosage Forms
|
|
WO2011109809A2
(en)
|
2010-03-05 |
2011-09-09 |
New Agriculture, Inc |
A novel composition of matter for delivering lipid-soluble materials, and a method for producing it
|
|
EP2547362B1
(en)
|
2010-03-17 |
2021-08-25 |
Cornell University |
Disrupted adenovirus-based vaccine against drugs of abuse
|
|
WO2011138142A1
(en)
|
2010-05-07 |
2011-11-10 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Compositions and use of sulfasalazine
|
|
AU2011250962B2
(en)
|
2010-05-10 |
2015-09-03 |
Gfbiochemicals Limited |
Personal care formulations containing alkyl ketal esters and methods of manufacture
|
|
US8362007B1
(en)
|
2010-05-11 |
2013-01-29 |
Demerx, Inc. |
Substituted noribogaine
|
|
US8765737B1
(en)
|
2010-05-11 |
2014-07-01 |
Demerx, Inc. |
Methods and compositions for preparing and purifying noribogaine
|
|
US20120108510A1
(en)
|
2010-05-20 |
2012-05-03 |
Emory University |
Methods of improving behavioral therapies
|
|
JP2012020991A
(ja)
|
2010-06-16 |
2012-02-02 |
Takasago Internatl Corp |
経皮吸収促進剤、及びこれを含有する皮膚外用製剤
|
|
US8802832B2
(en)
|
2010-06-22 |
2014-08-12 |
Demerx, Inc. |
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
|
|
CA2806232A1
(en)
|
2010-07-23 |
2012-01-26 |
Demerx, Inc. |
Noribogaine compositions
|
|
US20120039999A1
(en)
|
2010-08-11 |
2012-02-16 |
Ashish Chatterji |
Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
|
|
WO2012022928A2
(en)
|
2010-08-20 |
2012-02-23 |
Heptares Therapeutic Ltd |
Biological materials and uses thereof
|
|
WO2012074588A2
(en)
|
2010-08-30 |
2012-06-07 |
President And Fellows Of Harvard College |
Shear controlled release for stenotic lesions and thrombolytic therapies
|
|
WO2012031125A2
(en)
|
2010-09-01 |
2012-03-08 |
The General Hospital Corporation |
Reversal of general anesthesia by administration of methylphenidate, amphetamine, modafinil, amantadine, and/or caffeine
|
|
US20120129834A1
(en)
|
2010-09-17 |
2012-05-24 |
Buck Institute For Research On Aging |
Serotonin receptor antagonists for use in the treatment of huntington's disease
|
|
WO2012039660A1
(en)
|
2010-09-20 |
2012-03-29 |
A. Carlsson Research Ab |
Phenylpiperidine compounds for the treatment of neurological and psychiatric disorders
|
|
CA2816595C
(en)
|
2010-10-07 |
2018-11-27 |
Eaglepharma Pty Ltd |
Combination therapy for the treatment of depression and other non-infectious diseases
|
|
EP2629615B1
(en)
|
2010-10-22 |
2018-10-10 |
Duke University |
Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies
|
|
US20130230587A1
(en)
|
2010-11-10 |
2013-09-05 |
Rubicon Research Private Limited |
Sustained release compositions
|
|
TR201808178T4
(tr)
|
2010-11-15 |
2018-07-23 |
Neuroderm Ltd |
Aktif ajanların transdermal dağıtımı için bileşimler.
|
|
EP2649443A2
(en)
|
2010-12-06 |
2013-10-16 |
Ramot at Tel-Aviv University Ltd |
Methods and kits for detection of drugs
|
|
EP3834869B1
(en)
|
2010-12-22 |
2024-06-05 |
Syqe Medical Ltd. |
System for drug delivery
|
|
EP2481740B1
(en)
|
2011-01-26 |
2015-11-04 |
DemeRx, Inc. |
Methods and compositions for preparing noribogaine from voacangine
|
|
FR2971423B1
(fr)
|
2011-02-15 |
2014-01-10 |
Ceva Sante Animale |
Composition veterinaire antiprolactinique destinee aux ruminants
|
|
CN103502817B
(zh)
|
2011-03-28 |
2016-01-20 |
前视红外系统股份有限公司 |
包括药物的分析物的检测方法
|
|
US8742096B2
(en)
|
2011-03-28 |
2014-06-03 |
Demerx, Inc. |
Methods and compositions for preparing noribogaine from voacangine
|
|
TWI636784B
(zh)
|
2011-04-05 |
2018-10-01 |
大塚製藥股份有限公司 |
含7-〔4-(4-苯並〔b〕噻吩-4-基-哌-1-基)丁氧基〕-1H-喹啉-2-酮之醫藥組成物與套組，以及彼之用途
|
|
US20120282255A1
(en)
|
2011-04-07 |
2012-11-08 |
Greg Plucinski |
Methods and compositions for the treatment of alcoholism and alcohol dependence
|
|
KR20120128440A
(ko)
|
2011-05-17 |
2012-11-27 |
삼성전자주식회사 |
표적 물질 검출용 키트 및 이를 이용한 표적 물질 검출 방법
|
|
WO2012158892A2
(en)
|
2011-05-19 |
2012-11-22 |
Bruce Roseman |
A method of treating apraxia of speech in children
|
|
US20140163070A1
(en)
|
2012-05-17 |
2014-06-12 |
Bruce Roseman |
Treatment for cerebral palsy impaired speech in children
|
|
KR20140042868A
(ko)
|
2011-06-23 |
2014-04-07 |
맵 파마슈티컬스, 인코포레이티드 |
신규한 플루오로에르골린 유사체
|
|
US9040520B2
(en)
|
2011-09-15 |
2015-05-26 |
Demerx, Inc. |
Noribogaine salt ansolvates
|
|
WO2013061161A2
(en)
|
2011-10-28 |
2013-05-02 |
Green Bcn Consulting Services Sl |
New combination therapies for treating neurological disorders
|
|
RU2636350C2
(ru)
|
2011-11-07 |
2017-11-22 |
Новартис Аг |
МОЛЕКУЛА, СОДЕРЖАЩАЯ SPR0096 и SPR2021
|
|
FR2983409B1
(fr)
|
2011-12-06 |
2013-12-27 |
Ethypharm Sa |
Comprime susceptible de lutter contre le detournement par voie injectable
|
|
IN2014CN04160A
(https=)
|
2011-12-08 |
2015-07-17 |
Demerx Inc |
|
|
CA2855994A1
(en)
|
2011-12-09 |
2013-06-13 |
Demerx, Inc. |
Phosphate esters of noribogaine
|
|
EP2788356A4
(en)
|
2011-12-09 |
2015-10-21 |
Demerx Inc |
SULFATESTER FROM NORIBOGAIN
|
|
EP2607352A1
(en)
|
2011-12-22 |
2013-06-26 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pipecolate-diketoamides for treatment of psychiatric disorders
|
|
EP2610245A1
(en)
|
2011-12-28 |
2013-07-03 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pipecolate-sulfonamides for treatment of psychiatric disorders
|
|
CA2858820C
(en)
|
2012-01-25 |
2021-08-17 |
Demerx, Inc. |
Synthetic voacangine
|
|
EP2807167A4
(en)
|
2012-01-25 |
2016-01-20 |
Demerx Inc |
INDOIND AND BENZO FURANKED ISOCHINUCLIDEN DERIVATIVES AND METHOD FOR THE MANUFACTURE THEREOF
|
|
WO2013112163A1
(en)
|
2012-01-25 |
2013-08-01 |
Demerx, Inc. |
Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
|
|
EP2649989B1
(en)
|
2012-04-13 |
2017-10-18 |
King Saud University |
Method for preparing a solid dispersion, solid dispersion obtained thereby and use thereof
|
|
US20130295170A1
(en)
|
2012-05-03 |
2013-11-07 |
Kydes Pharmaceuticals Llc |
Compositions for control of drug abuse
|
|
US20130295016A1
(en)
|
2012-05-07 |
2013-11-07 |
David J. Gerber |
Signatures of electroencephalographic oscillations
|
|
CN104411316B
(zh)
|
2012-05-09 |
2018-05-01 |
坎泰克斯制药股份有限公司 |
骨髓抑制的治疗
|
|
US8784835B2
(en)
|
2012-07-02 |
2014-07-22 |
Trent Austin |
Method for producing muscimol and/or reducing ibotenic acid from amanita tissue
|
|
US20150196533A1
(en)
|
2012-07-02 |
2015-07-16 |
The General Hospital Corporation |
Method for concurrent treatment of pain and depression
|
|
EP2690102A1
(en)
|
2012-07-24 |
2014-01-29 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Bicyclic aza-amides for treatment of psychiatric disorders
|
|
EP2884962B1
(en)
|
2012-08-17 |
2019-05-01 |
Smartek International LLC |
Preparation of desiccated liposomes for use in compressible delivery systems
|
|
CA2882870C
(en)
|
2012-08-24 |
2020-12-15 |
Integurx Therapeutics, Llc |
Chemical compositions and methods for enhancing transdermal delivery of therapeutic agents
|
|
US20140066881A1
(en)
|
2012-08-31 |
2014-03-06 |
Zoll Medical Corporation |
Cardiac resuscitation methods and kits
|
|
US20140100282A1
(en)
|
2012-10-10 |
2014-04-10 |
Patrick S L Wong |
Intranasal administration of pharmaceutical agents for treatment of neurological diseases
|
|
US20150231300A1
(en)
|
2012-10-28 |
2015-08-20 |
Peritech Pharma Ltd. |
Pharmaceutical liquid adhesive compositions for treatment of anorectal disorders
|
|
WO2014078857A1
(en)
|
2012-11-19 |
2014-05-22 |
Regents Of The University Of Minnesota |
Ergoline derivatives as dopamine receptor modulators
|
|
EP2931291B1
(en)
|
2012-12-11 |
2021-10-20 |
The McLean Hospital Corporation |
Xenon treatment as an adjunct to psychotherapy for psychiatric disorders
|
|
CA2896133A1
(en)
|
2012-12-20 |
2014-06-26 |
Demerx, Inc. |
Substituted noribogaine
|
|
US10555916B2
(en)
|
2013-01-25 |
2020-02-11 |
Case Western Reserve University |
NMDAR antagonist for the treatment of pervasive development disorders
|
|
US20140294923A1
(en)
|
2013-02-20 |
2014-10-02 |
Questcor Pharmaceuticals, Inc. |
Acth for treatment of migraine headache
|
|
WO2014140925A2
(en)
|
2013-03-10 |
2014-09-18 |
Peritech Pharma Ltd. |
Topical compositions and methods of treatment of topical disorders
|
|
US20140288454A1
(en)
|
2013-03-14 |
2014-09-25 |
Pulmonary Analytics |
Method For Using Exhaled Breath to Determine the Presence of Drug
|
|
WO2014146082A1
(en)
|
2013-03-15 |
2014-09-18 |
Bhl Patent Holdings Llc |
Materials and methods for treating neuropathies and related disorders including those involving a keystone nerve
|
|
CA2942638C
(en)
|
2013-03-15 |
2026-03-10 |
Demerx, Inc. |
Method for noribogaine treatment of addiction in patients on methadone
|
|
BR112015023116A2
(pt)
|
2013-03-15 |
2017-07-18 |
Melior Discovery Inc |
composto, composição, formulação para administração oral, método de tratamento de um distúrbio, e, uso de um composto
|
|
WO2014142938A1
(en)
|
2013-03-15 |
2014-09-18 |
Aihol Corporation |
Pharmaceutical formulation containing glycosaminoglycan
|
|
WO2014176556A1
(en)
|
2013-04-26 |
2014-10-30 |
Express Diagnostics International, Inc. |
Portable testing system for detecting selected drugs or compounds in non-controlled environments
|
|
WO2014186623A2
(en)
|
2013-05-17 |
2014-11-20 |
Biomed Valley Discoveries |
Methods and compositions for the treatment of a chagas disease
|
|
US9737490B2
(en)
|
2013-05-29 |
2017-08-22 |
Grünenthal GmbH |
Tamper resistant dosage form with bimodal release profile
|
|
CA2817728A1
(en)
|
2013-05-31 |
2014-11-30 |
Pharmascience Inc. |
Abuse deterrent immediate release formulation
|
|
US20160128944A1
(en)
|
2013-06-04 |
2016-05-12 |
Vyome Biosciences Pvt. Ltd. |
Coated particles and compositions comprising same
|
|
US20140364367A1
(en)
|
2013-06-08 |
2014-12-11 |
Sedogen, Llc |
Methods of treating prader willi syndrome and conditions associated with low basal metabolic rate or hyperphagia using a katp channel opener
|
|
EP2818177A1
(en)
|
2013-06-24 |
2014-12-31 |
Celica, D.O.O. |
Mechanism and drug targets for reducing cell edema (neuroprotection) and cytoplasmic excitability in astrocytes in normal and pathological states
|
|
CN105338974A
(zh)
|
2013-07-03 |
2016-02-17 |
阿库拉制药公司 |
阻止滥用的方法和组合物
|
|
CN105473545B
(zh)
|
2013-07-08 |
2017-08-04 |
奥斯拜客斯制药有限公司 |
二羟苯基神经递质化合物、组合物以及方法
|
|
BR112016000194A8
(pt)
|
2013-07-12 |
2019-12-31 |
Gruenenthal Gmbh |
forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
|
|
CA2918223A1
(en)
*
|
2013-07-17 |
2015-01-22 |
Araim Pharmaceuticals, Inc. |
Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
|
|
US9770514B2
(en)
|
2013-09-03 |
2017-09-26 |
ExxPharma Therapeutics LLC |
Tamper-resistant pharmaceutical dosage forms
|
|
US10098893B2
(en)
|
2013-10-03 |
2018-10-16 |
Northwestern University |
Methods of administering a trace amine-associated receptor 1 (TAAR1) agonist to patients having the minor allele of the single nucleotide polymorphism rs2237457
|
|
US9474481B2
(en)
|
2013-10-22 |
2016-10-25 |
Mindstrong, LLC |
Method and system for assessment of cognitive function based on electronic device usage
|
|
US9420970B2
(en)
|
2013-10-22 |
2016-08-23 |
Mindstrong, LLC |
Method and system for assessment of cognitive function based on mobile device usage
|
|
MX2016005477A
(es)
|
2013-10-31 |
2016-08-03 |
Cima Labs Inc |
Formas de dosificacion disuasivas del abuso.
|
|
US20150118300A1
(en)
|
2013-10-31 |
2015-04-30 |
Cima Labs Inc. |
Immediate Release Abuse-Deterrent Granulated Dosage Forms
|
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
TW201605856A
(zh)
|
2013-11-01 |
2016-02-16 |
艾尼納製藥公司 |
５－ＨＴｃ受體促效劑
|
|
CN103549133A
(zh)
|
2013-11-05 |
2014-02-05 |
杨剑 |
有机猪牧草饲料
|
|
CN103535561A
(zh)
|
2013-11-05 |
2014-01-29 |
杨剑 |
饲养大猪用的牧草饲料
|
|
CN103751943B
(zh)
|
2014-01-13 |
2020-10-13 |
湖北及安盾消防科技有限公司 |
一种含有含氮类有机化合物的灭火组合物
|
|
AU2014379612A1
(en)
|
2014-01-24 |
2016-08-11 |
Demerx, Inc. |
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
|
|
CN103773056B
(zh)
|
2014-01-24 |
2015-11-18 |
山东大学 |
高脆性透明类岩石材料试件制备方法
|
|
CA2978537C
(en)
|
2014-03-03 |
2023-10-24 |
Demerx, Inc. |
Therapeutic uses of ibogaine and related compounds
|
|
US20150258114A1
(en)
|
2014-03-13 |
2015-09-17 |
Demerx, Inc. |
Methods for acute and long-term treatment of substance abuse using ibogaine
|
|
EP3151906B1
(en)
|
2014-06-03 |
2019-12-11 |
Pop Test Abuse Deterrent Technology LLC |
Drug device configured for wireless communication
|
|
US10202426B2
(en)
|
2014-07-30 |
2019-02-12 |
Genome Protection, Inc. |
Flagellin compositions and uses
|
|
US10231651B2
(en)
|
2014-09-25 |
2019-03-19 |
Bae Systems Information And Electronic Systems Integration Inc. |
Gait authentication system and method thereof
|
|
US10058253B2
(en)
|
2014-11-11 |
2018-08-28 |
Zenmark, Llc |
System, method, and article for heart rate variability monitoring
|
|
WO2016145193A1
(en)
|
2015-03-10 |
2016-09-15 |
Eleusis Benefit Corporation, Pbc |
Lsd for the treatment of alzheimer's disease
|
|
EP3275448B1
(en)
|
2015-03-24 |
2025-10-29 |
Kyowa Kirin Co., Ltd. |
Nucleic acid-containing lipid nanoparticles
|
|
US10254298B1
(en)
|
2015-03-25 |
2019-04-09 |
National Technology & Engineering Solutions Of Sandia, Llc |
Detection of metabolites for controlled substances
|
|
ES2882588T3
(es)
*
|
2015-03-31 |
2021-12-02 |
Turtle Bear Holdings Llc |
Actividad antiviral de setas medicinales y sus constituyentes activos
|
|
MX373319B
(es)
|
2015-04-27 |
2020-06-13 |
Arena Pharm Inc |
Derivados de hexahidro-[1-4]diazepino[6,7,1-hi]indol-8-carboxamida como agonistas del receptor 5-ht2c y el uso de los mismos en el tratamiento de enfermedades relacionadas con dicho receptor.
|
|
CA2952818A1
(en)
|
2015-05-01 |
2016-11-10 |
Eran Eilat |
Compositions for the treatment of epistaxis
|
|
US20180147142A1
(en)
|
2015-05-19 |
2018-05-31 |
Joseph Robert Knight |
Method for isolation of alkaloids and amino acids, and compositions containing isolated alkaloids and amino acids
|
|
WO2016187277A1
(en)
|
2015-05-19 |
2016-11-24 |
Joseph Robert Knight |
Method for isolation of alkaloids and amino acids, and compositions containing isolated alkaloids and amino acids
|
|
US9737759B2
(en)
|
2015-07-17 |
2017-08-22 |
Genesant Technologies, Inc. |
Automatic application-based exercise tracking system and method
|
|
MA42527A
(fr)
|
2015-07-31 |
2021-04-07 |
Arena Pharm Inc |
Agonistes de récepteur 5-ht2c et compositions et procédés d'utilisation
|
|
US9614734B1
(en)
|
2015-09-10 |
2017-04-04 |
Pearson Education, Inc. |
Mobile device session analyzer
|
|
JP2019523633A
(ja)
*
|
2016-04-29 |
2019-08-29 |
アライム ファーマシューティカルズ，インコーポレーテッド |
組織の損傷に関連した疾患及び障害を予防及び治療する組織保護ペプチド
|
|
US20180021326A1
(en)
|
2016-07-23 |
2018-01-25 |
Paul Edward Stamets |
Compositions and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or hericenones enhanced with niacin
|
|
US20210069170A1
(en)
|
2016-07-23 |
2021-03-11 |
Paul Edward Stamets |
Tryptamine compositions for enhancing neurite outgrowth
|
|
EA038219B1
(ru)
|
2016-08-19 |
2021-07-26 |
Арена Фармасьютикалз, Инк. |
Агонисты рецептора 5-ht2c и композиции, а также способ их применения
|
|
US10596378B2
(en)
|
2016-10-18 |
2020-03-24 |
Joseph Rustick |
Method for treatment of depression using synaptic pathway training
|
|
US20180195455A1
(en)
|
2017-01-12 |
2018-07-12 |
GM Global Technology Operations LLC |
Engine combustion phasing control during transient state
|
|
NL2018190B1
(en)
*
|
2017-01-18 |
2018-07-26 |
Procare Beheer B V |
Psilocybin or psilocin in combination with cannabinoid
|
|
EP3576755A4
(en)
|
2017-02-02 |
2020-12-02 |
McMaster University |
BICARBONATE AS A POTENTIALIZER OF ANTIMICROBIAL AGENTS
|
|
US20190142851A1
(en)
|
2017-11-16 |
2019-05-16 |
CaaMTech, LLC |
Compositions comprising a psilocybin derivative and a cannabinoid
|
|
WO2018145219A1
(es)
|
2017-02-09 |
2018-08-16 |
Serani Mostazal Jorge |
Composición farmaceutica para la prevención y tratamiento de las adicciones a traves de un contracondicionamiento aversivo
|
|
CA3052974A1
(en)
*
|
2017-02-09 |
2018-08-16 |
CaaMTech, LLC |
Compositions and methods comprising a psilocybin derivative
|
|
CN108619214A
(zh)
|
2017-03-15 |
2018-10-09 |
王慎君 |
一种治疗肿瘤的药物
|
|
NZ757591A
(en)
|
2017-03-30 |
2026-03-27 |
Ojai Energetics Pbc |
Methods and compositions for enhancing health
|
|
AU2017408099A1
(en)
|
2017-04-07 |
2019-11-07 |
ACEA Therapeutics, Inc. |
Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same
|
|
US20200147038A1
(en)
|
2017-04-20 |
2020-05-14 |
Eleusis Benefit Corporation, Pbc |
Assessing and treating psychedelic-responsive subjects
|
|
US20190246591A1
(en)
|
2017-05-31 |
2019-08-15 |
Insectergy, Llc |
Insect and cannabis production systems and methods
|
|
US20180343812A1
(en)
|
2017-05-31 |
2018-12-06 |
Insectergy, Llc |
Cannabis farming systems and methods
|
|
EP3629899A4
(en)
|
2017-06-02 |
2021-04-21 |
Northwestern University |
Thin, soft, skin-mounted microfluidic networks for detection and analysis of targets of interest in sweat
|
|
CN107252080A
(zh)
|
2017-07-12 |
2017-10-17 |
沈建国 |
一种麻菇酱油的配方
|
|
GB2571696B
(en)
|
2017-10-09 |
2020-05-27 |
Compass Pathways Ltd |
Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
|
|
US12459965B2
(en)
|
2017-10-09 |
2025-11-04 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
JP2021500948A
(ja)
|
2017-10-19 |
2021-01-14 |
エレウシス ヘルス ソリューションズ ユーエス インコーポレイテッド |
サイケデリック薬剤療法の安全性を向上させる方法およびシステム
|
|
MA50786A
(fr)
|
2017-10-26 |
2022-04-27 |
Blumentech S L |
Produit d'association pour le traitement de troubles neurologiques et/ou psychiatriques
|
|
US10703325B2
(en)
|
2017-11-27 |
2020-07-07 |
Autoliv Asp, Inc. |
Multi-chambered side airbag assemblies
|
|
EP3720506A4
(en)
|
2017-12-04 |
2021-09-29 |
Lecouteur, David |
COMPOSITIONS AND METHODS FOR MODULATING THE WINDOWS OF HEPATIC ENDOTHELIAL CELLS
|
|
FI128750B
(en)
|
2017-12-21 |
2020-11-30 |
Helsingin Yliopisto |
Methods for determining the therapeutic effect of fast-acting antidepressants and related individual antidepressant therapy
|
|
WO2019144140A1
(en)
|
2018-01-22 |
2019-07-25 |
CyPhi LLC |
Bio-mimetic formulation
|
|
WO2019161050A1
(en)
|
2018-02-18 |
2019-08-22 |
Akili Interactive Labs, Inc. |
Cognitive platform including computerized elements coupled with a therapy for mood disorder
|
|
MX2020009254A
(es)
|
2018-03-08 |
2021-01-15 |
New Atlas Biotechnologies Llc |
Procesos para la produccion de triptaminas.
|
|
FI129102B
(en)
|
2018-03-19 |
2021-07-15 |
Teknologian Tutkimuskeskus Vtt Oy |
Heterological production of psilosybin
|
|
WO2019213551A1
(en)
|
2018-05-04 |
2019-11-07 |
Perception Neuroscience, Inc. |
Methods of treating substance abuse
|
|
CA3148256A1
(en)
|
2018-06-21 |
2019-12-26 |
Robert John Petcavich |
Method of inducing dendritic and synaptic genesis in neurodegenerative chronic diseases
|
|
EP3829640A4
(en)
|
2018-08-01 |
2022-05-25 |
McMaster University |
Methods for inhibiting microbe growth
|
|
US12090145B2
(en)
|
2018-08-20 |
2024-09-17 |
Yale University |
Combination therapy for treating or preventing depression or other mood diseases
|
|
US11337937B2
(en)
*
|
2018-08-27 |
2022-05-24 |
ReJoy |
TARR receptor agonists for sexual dysfunction
|
|
WO2020053196A1
(en)
|
2018-09-10 |
2020-03-19 |
Universität Basel |
Method for the biocatalytic alkylation of a substrate
|
|
WO2020142259A1
(en)
|
2019-01-04 |
2020-07-09 |
Apollo Neuroscience, Inc. |
Systems and methods of wave generation for transcutaneous vibration
|
|
MA54877A
(fr)
|
2019-01-30 |
2021-12-08 |
Diamond Therapeutics Inc |
Compositions et méthodes comprenant un agoniste de récepteur 5ht destinées au traitement de troubles psychologiques, cognitifs, comportementaux et/ou d'humeur
|
|
FI4349407T3
(fi)
|
2019-02-22 |
2025-06-02 |
Gh Res Ireland Limited |
5-metoksi-n,n-dimetyylitryptamiini (5-meo-dmt) vaikean masennuksen hoitoon
|
|
US12377112B2
(en)
|
2019-04-17 |
2025-08-05 |
Compass Pathfinder Limited |
Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
|
|
US20210015738A1
(en)
|
2019-07-17 |
2021-01-21 |
Concept Matrix Solutions |
Oral dissolvable film containing psychedelic compound
|
|
US11766445B2
(en)
|
2019-07-18 |
2023-09-26 |
Concept Matrix Solutions |
Oral soft gel capsule containing psychedelic compound
|
|
EP4178569A4
(en)
|
2020-07-10 |
2024-07-31 |
Eleusis Therapeutics US, Inc. |
Method of treatment for psilocybin or psilocin infusion
|
|
EP4009026B1
(en)
|
2020-12-02 |
2024-09-18 |
Volvo Truck Corporation |
An air-actuated vehicle system and a method of detecting leakage in an air-actuated vehicle system
|
|
TW202304466A
(zh)
|
2021-03-30 |
2023-02-01 |
英商康派斯開拓者公司 |
賽洛西賓（ｐｓｉｌｏｃｙｂｉｎ）組成物，其製備方法及使用方法
|
|
WO2023086252A1
(en)
|
2021-11-09 |
2023-05-19 |
Compass Pathfinder Limited |
Treatment of treatment resistant depression with psilocybin
|
|
AU2023319280A1
(en)
|
2022-08-05 |
2025-03-20 |
Mindset Pharma Inc. |
3-ethylamino-indole dimers as serotonergic agents useful for the treatment of disorders related thereto
|
